ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Patient questionnaires"

  • Abstract Number: 430 • ACR/ARP Annual Meeting 2019

    Axial Spondyloarthritis Patients Report Important Impairments in Daily Life and Work Ability – a Web Survey in 472 Patients

    Sebastian Ibanez1, Rianne van Bentum 2, Omar Valenzuela 3 and Irene van der Horst-Bruinsma 2, 1Facultad de Medicina Clinica Alemana - UDD, Santiago, Region Metropolitana, Chile, 2Amsterdam University Medical Center, Amsterdam, Netherlands, 3Facultad de Medicina Clinica Alemana -UDD, Santiago, Region Metropolitana, Chile

    Background/Purpose: Axial spondyloarthritis (axSpA) can be associated with significant burden and impaired work activity. In Chile, several barriers impede adequate treatment, such as insufficient access…
  • Abstract Number: 648 • ACR/ARP Annual Meeting 2019

    Patients of African Descent Score Higher on Quality of Life Indices Despite Their Known Disease Severity

    Katie Zuech1, Ly Tran 2, Teresa Aberle 1, Cristina Arriens 3, Eliza F. Chakravarty 3, Joan T. Merrill 4 and Judith James 3, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City, 3Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 4Okalahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose:  Systemic lupus (SLE) may have a significant impact on multiple dimensions of quality of life. Patient-reported outcome (PRO) tools may provide valuable insights for…
  • Abstract Number: 662 • ACR/ARP Annual Meeting 2019

    Utility of a Mobile Phone Based Application to Collect Patient-Reported Outcome Information from People Living with Systemic Lupus Erythematosus

    Brooke Williams1, Bridget Muckian 1, Claire Dykas 2, Christine Peschken 3, Richard Furie 4, Elena Massarotti 5, Vanja sikirica 6, Steven Gilbert 7, Martin Hodge 7 and Peter Lipsky 8, 1AMPEL BioSolutions, Charlottesville, VA, 2AmpelBioSolutions, Charlottesville, VA, 3University of Manitoba, Winnepeg, Canada, 4Northwell Health, Great Neck, NY, 5Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 6Pfizer, Boston, MA, 7Pfizer, Boston, 8AMPEL BioSolutions, LLC, Charlottesville, VA

    Background/Purpose: Patient Reported Outcomes (PROs) can provide important data about the impact of a disease on an individual and/or the quality of the response to…
  • Abstract Number: 2256 • ACR/ARP Annual Meeting 2019

    Patient Beliefs and Perceptions of Methotrexate for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis

    W. Benjamin Nowell1, Elaine Karis 2, Kelly Gavigan 1, Laura Stradford 1, Scott Stryker 3, Shilpa Venkatachalam 1, Gregory Kricorian 3 and Jeffrey Curtis 4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2Amgen Inc, Thousand Oaks, CA, 3Amgen Inc., Thousand Oaks, CA, 4University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Methotrexate (MTX) is a frequently used therapy in both Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) due to its beneficial effects in both populations.…
  • Abstract Number: 1428 • ACR/ARHP Annual Meeting 2018

    Parental Involvement and Adolescents/Young Adults Self-Management during the Transition Period: A Cross-Sectional Survey in Childhood Onset Rheumatic Diseases

    Pauline Yi1, Hana Conlon2, Jae Hee Yun3, Kayla Neville2, George Danias2, Anca Askanase4 and Lisa F. Imundo5, 1Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Rheumatology, Columbia University Medical Center, New York, NY, 3Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 4Columbia University, College of Physicians & Surgeons, New York, NY, 5Pediatrics, Columbia University Medical Center, New York, NY

    Background/Purpose: A NIH focus group study found that adolescents and young adults (AYA) with active disease relied heavily on their parents for disease management. It…
  • Abstract Number: 1643 • ACR/ARHP Annual Meeting 2018

    Psa Impact of Disease Questionnaire Scores Are Correlated with Disease Activity, As Measured By Cdapsa in Patients with Psa

    Ana-Maria Orbai1, Klaus Krüger2, Frank Behrens3, Uta Kiltz4, Benoit Guerette5, Lillian Mellars5, Michele Brunori5 and Jürgen Wollenhaupt6, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Medical Centre of Rheumatology, Munich, Germany, 3Clinical Research Rheumatology and Fraunhofer Institute IMETranslation, Goethe University, Frankfurt, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Celgene Corporation, Summit, NJ, 6Schön-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany

    Background/Purpose: We examined clinical correlations between disease activity, as measured with the Clinical Disease Activity for PsA (cDAPSA) components and PsA life impact/health-related quality of…
  • Abstract Number: 353 • ACR/ARHP Annual Meeting 2017

    Patient Experiences of Rheumatoid Arthritis Models of Care: An International Survey

    Cheryl L. Koehn1, Kelly Lendvoy1, Yue Ma2, Linda Li3, Alison Hoens4, Marion Souveton5 and John M. Esdaile4, 1Arthritis Consumer Experts, Vancouver, BC, Canada, 2Simon Fraser University, Burnaby, BC, Canada, 3Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, 4Arthritis Research Canada, Richmond, BC, Canada, 5F. Hoffmann-La Roche Ltd, Basel, Switzerland

    Background/Purpose: Despite the global prevalence of rheumatoid arthritis (RA), there is no single model of care (MoC) and little is known about the RA patient…
  • Abstract Number: 475 • ACR/ARHP Annual Meeting 2017

    Rheumatoid Arthritis Patient Characteristics Also Predict Response to Therapy with Biologic Agents: Results from the Corrona Certain Study

    Dimitrios A. Pappas1, James Murray2, Carol J. Etzel1, David R Nelson2, Bernice Gershenson3, Katherine C. Saunders1, Sabrina Rebello1 and Joel Kremer4, 1Corrona, LLC, Southborough, MA, 2Eli Lilly and Company, Indianapolis, IN, 3University of Massachusetts Medical School, Worcester, MA, 4Albany Medical College and The Center for Rheumatology, Albany, NY

    Background/Purpose: Response to biologic agents approved for RA may be associated with patient reported factors that are not related to disease and usually not included…
  • Abstract Number: 1253 • ACR/ARHP Annual Meeting 2017

    Patient Reported Outcomes Explain the Lack of Agreement between Physician and Patient Perceived Remission in Early Rheumatoid Arthritis

    Samina A. Turk1,2, Linda A. Rasch3, Willem F. Lems4,5, Lilian van Tuyl3, Dirkjan van Schaardenburg4,6 and Marieke M. Ter Wee5,7, 1Rheumatology, Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Rheumatology, Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 3Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 4Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 5Rheumatology, Amsterdam Rheumatology and immunology Center | VU University Medical Center, Amsterdam, Netherlands, 6Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands, 7Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) patients increasingly reach a state of absence of disease activity, or remission. However, the proportion of patients classified as in remission…
  • Abstract Number: 2220 • ACR/ARHP Annual Meeting 2017

    Neuropathic-like Pain Affects the Tender Joint Count and Health-Related Quality of Life in Patients with Rheumatoid Arthritis

    Kentaro Noda1, Miku Tajima2, Yosuke Oto3, Kazuhiro Otani3, Yoshiga Masayuki3, Haruyasu Ito1, Ken Yoshida1 and Daitaro Kurosaka1, 1Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medecine, Jikei University School of Medicine, Tokyo, Japan, 3Internal Medicine, Jikei University School of Medicine, Tokyo, Japan

    Background/Purpose: Pain in rheumatoid arthritis (RA) has been thought to be due to nociceptive pain, but it was reported recently to include a mechanism associated…
  • Abstract Number: 81 • ACR/ARHP Annual Meeting 2016

    Understanding the Importance of a Patient’s Role in the Management of RA: Physician- and Patient-Based Survey

    Ara Dikranian1, James Galloway2, Joern Kekow3, Cristiano A.F Zerbini4, Maria de la Vega5, Gavin Lee6, Anna Maniccia7, Eustratios Bananis8, Dario Ponce de Leon9 and Allan Gibofsky10, 1San Diego Arthritis Medical Clinic, San Diego, CA, 2King's College, and King´s College Hospital, London, United Kingdom, 3University of Magdeburg, Clinic of Rheumatology, Magdeburg, Germany, 4Centro Paulista de Investigação Clinica, São Paulo, Brazil, 5CEIM Investigaciones Médicas, Buenos Aires, Argentina, 6Hong Kong Sanatorium & Hospital, Hong Kong SAR, China, 7Pfizer Inc, New York, NY, 8Pfizer Inc, Collegeville, PA, 9Pfizer Inc, Lima, Peru, 10Rheumatology, Weill Cornell Medicine, and Hospital for Special Surgery, New York, NY

    Background/Purpose: RA is a chronic, debilitating condition for which there is no cure. To identify and better understand the perspectives of both healthcare providers (HCPs)…
  • Abstract Number: 1432 • ACR/ARHP Annual Meeting 2016

    The EULAR Systemic Sclerosis Impact of Disease Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis Under Development

    Rucsandra Dobrota1, Mike Becker2, Kim Fligelstone3,4, Jaap Fransen5, Ann Kennedy6, Yannick Allanore7, Patricia Carreira8, László Czirják9, Christopher Denton10, Roger Hesselstrand11, Gunnel Sandqvist11, Otylia Kowal-Bielecka12, Marco Matucci Cerinic13, Carina Mihai14, Ana Maria Gheorghiu15, Ulf Müller-Ladner16, Marc Frerix17, Turid Heiberg18 and Oliver Distler1, 1Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Royal Free Hospital, Scleroderma Unit and Scleroderma Society, London, United Kingdom, 4Federation of European Scleroderma Associations (FESCA), London, United Kingdom, 5Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 6Federation of European Scleroderma Associations (FESCA), Tournai, Belgium, 7Department of Rheumatology, University Paris Descartes and Cochin Hospital, Paris, France, 8Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 9Department of Rheumatology and Immunology, University of Pécs, Faculty of Medicine, Pécs, Hungary, 10Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 11Department of Rheumatology, Lund University, Lund, Sweden, 12Department of Rheumatology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland, 13Department of Rheumatology, University of Florence, Florence, Italy, 14Department of Internal Medicine and Rheumatology, Carol Davila University of Medicine and Pharmacy, Cantacuzino Hospital, Bucharest, Romania, 15Carol Davila University of Medicine and Pharmacy, Internal Medicine and Rheumatology Department, Cantacuzino Clinical Hospital, Bucharest, Romania, 16Department of Internal Medicine and Rheumatology, Justus-Liebig-University Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 17Department of Rheumatology and Clinical Immunology, Justus-Liebig-University Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 18Department of Health and Social Sciences, Oestfold University College, Oslo, Norway

    Background/Purpose: Patient reported outcome measures (PROM) are required as key outcomes in disease modifying therapeutic trials in systemic sclerosis (SSc). A PROM tool in SSc,…
  • Abstract Number: 2629 • ACR/ARHP Annual Meeting 2015

    The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire

    Laure Gossec1,2, Pierre Chauvin3,4, Christophe Hudry5, Florence Mathoret-Philibert6, Maud Poussière7, Thibault de Chalus8, Francoise Russo-Marie9, Jean-Michel Joubert8, Alain Saraux10 and Francis Berenbaum1,11, 1Rheumatology Department, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, 2Rheumatology Department, AP-HP, Hôpital Pitié Salpêtrière, Paris, France, 3Department of Social Epidemiology, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, 4Department of Social Epidemiology, Pierre Louis Institute of Epidemiology and Public Health, Paris, France, 5Rheumatology, AP-HP, Hôpital Cochin, Paris, France, 6Clinical Psychology Department, AP-HP, Hôpital Cochin, Paris, France, 7Independent Researcher, Paris, France, 8UCB Pharma, Colombes, France, 9Arthritis Foundation Courtin, Neuilly-sur-Seine, France, 10Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 11Rheumatology Department, AP-HP, Hôpital Saint-Antoine, Paris, France

    Background/Purpose: Patients with chronic inflammatory disorders such as rheumatoid arthritis (RA) or spondyloarthritis (SpA) create personal sets of fears and beliefs related to their disease.…
  • Abstract Number: 2632 • ACR/ARHP Annual Meeting 2015

    Development and Validation of a Questionnaire Assessing the Fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases

    Laure Gossec1,2, Alain Saraux3, Christophe Hudry4, Florence Mathoret-Philibert5, Maud Poussière6, Thibault de Chalus7, Francoise Russo-Marie8, Jean-Michel Joubert7, Pierre Chauvin9 and Francis Berenbaum1,10, 1Rheumatology Department, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, 2Rheumatology Department, AP-HP, Hôpital Pitié Salpêtrière, Paris, France, 3Rheumatology Department, CHU de la Cavale Blanche, Brest Cedex, France, 4Rheumatology, AP-HP, Hôpital Cochin, Paris, France, 5Clinical Psychology Department, AP-HP, Hôpital Cochin, Paris, France, 6Independent Researcher, Paris, France, 7UCB Pharma, Colombes, France, 8Arthritis Foundation Courtin, Neuilly-sur-Seine, France, 9Department of Social Epidemiology, Sorbonne Universités, Université Pierre et Marie Curie, Paris, France, 10Rheumatology Department, Hôpital Saint-Antoine, Paris, France

    Background/Purpose: Questionnaires assessing the beliefs of patients with chronic rheumatic diseases mainly focus on medications.1A validated questionnaire evaluating patients' fears and beliefs towards their disease…
  • Abstract Number: 26 • ACR/ARHP Annual Meeting 2015

    Higher Scores of Women Compared to Men for Most Clinical Measures of Rheumatoid Arthritis (RA) Status: Greater Differences for Patient Self-Report Scores Than for Rheumatologist Estimates: A Cross-Sectional 3 Center Study from Routine Care

    Isabel Castrejón1, Martin Bergman2, Yusuf Yazici3, Annie Huang1, Joel A. Block1 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Division of Rheumatology, Taylor Hospital, Ridley Park, PA, 3NYU Hospital for Joint Diseases, New York, NY

    Background/Purpose: Higher scores for women compared to men have been reported for all 7 rheumatoid arthritis (RA) Core Data Set measures (1, 2). Most of…
  • 1
  • 2
  • Next Page

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology